Key Insights

Highlights

Research Leaders

12 sponsors active, led by Research Group Dirk Bumann

Related Conditions

Often studied with 7 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

Trial Status

Recruiting1

Clinical Trials (1)

Research Network

Active Sponsors

  • Research Group Dirk Bumann1
  • Loessner Group1
  • Nexus1
  • Sunagawa Group1
  • Boyman Group1

Top Investigators

Related Conditions

  • Chronic Pelvic Pain1
  • Nonmuscleinvasive Bladder Cancer1
  • Acute Catheterassociated Uti Cauti1
  • Recurrent Catheterassociated Uti Cauti1
  • Asymptomatic Bacteriuria In Subjects Relying On Some Type Of Catheter1

Activity Timeline